DARK SECRETS: Cron | Rare Historical Photos

Cronos Stock Is Getting New Life as Shares Hit a 6-Month High

Cronos (CRON) has demonstrated robust technical momentum, with shares up more than 20% over the past year. CRON maintains a 100% “Buy” rating from Barchart. Revenue is projected to grow 39% this year and 15.78% next year, supporting positive sentiment from analysts and investors. The company focuses on brand growth,...

Barchart · Aug 14

Cronos Group Q1 Earnings Call Highlights

Cronos Group (NASDAQ:CRON) reported record first-quarter 2026 net revenue and gross profit, with management pointing to growth in Israel, gains for its Spinach brand in Canada and continued international expansion as key drivers of the quarter. Chairman, President and CEO Mike Gorenstein said Crono

MarketBeat · May 11

4 Cannabis Stocks Log Momentum Gains Even As Congress Re-Criminalizes Some THC Products In Spending Bill

Four cannabis stocks are demonstrating significant technical momentum, seemingly undeterred by new regulatory headwinds from Washington.

Benzinga · Nov 14, 2025

Should You Buy Shares of Cronos Group (CRON) in July?

Cannabis producer Cronos Group (CRON) is experiencing turbulent times with weakening sales and losses. So, will it be worth investing in the stock now? Read on.

StockNews.com · Jul 4, 2023

Cronos Group (CRON) vs. MariMed (MRMD): Which Stock Are Investors Buying?

With evolving food consumption trends, favorable government policies and funding, and the adoption of cutting-edge technologies, the agricultural industry is well-placed to experience significant growth in the long run. So, let’s compare prominent agriculture stocks Cronos Group (CRON) and MariMed (MRMD) to identify which is gaining immense popularity among investors.…

StockNews.com · Jun 27, 2023

Is Cronos Group (CRON) a Good Buy?

Despite the growing market for recreational cannabis, Cronos Group (CRON) has failed to surpass its consensus EPS and revenue estimates during the first quarter. However, given its substantial cash reserves and no long-term debt, is CRON a good buy now? Keep reading.

StockNews.com · Jun 2, 2023

Sell the Farm on These 4 Cannabis Stocks

Despite significant growth in recent years driven by increased legalization, the cannabis industry took a hit last year amid economic and industry-wide headwinds, including stubborn supply gluts. Furthermore, the industry will likely remain under pressure this year due to economic challenges. Hence, it could be wise to avoid fundamentally weak…

StockNews.com · Mar 21, 2023

3 Agriculture Stocks to Feed Your Portfolio in 2023 And 1 to Sell

The rapid adoption of innovative technologies and growing sustainability and vertical farming initiatives should boost the global agriculture market. Hence, fundamentally strong agricultural stocks Archer-Daniels-Midland (ADM), Nutrien (NTR), and Dole (DOLE) could be ideal buys now. However, considering the macro headwinds, fundamentally weak Cronos Group (CRON) might be best avoided.…

StockNews.com · Feb 17, 2023

4 Agriculture Stocks With Room to Grow in 2023 and 1 to Sell

The agriculture industry is evoling amid the adoption of innovative technologies. The industry looks poised to witness solid growth in the coming years. Therefore, we think agriculture stocks Archer-Daniels-Midland (ADM), Nutrien (NTR), Mosaic (MOS), and CF Industries (CF) are ideal buys now. However, Cronos (CRON) might be best avoided given…

StockNews.com · Feb 7, 2023

SEC Charges Canada's Cronos Group And Former CCO William Hilson With Accounting Fraud

Cronos Group, Inc, (NASDAQ: CRON) announced that it had reached final settlement agreements with each of the U.S.

Benzinga · Oct 24, 2022